Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

STCUBE to merge with Korea-based biomedical company

Thursday, 10 Apr 2014 04:12am EDT 

STCUBE INC:To merge with Korea-based biomedical company, which is engaged in the medical institutions consulting, research and development new medicine for anticancer agent, to increase competitiveness.Merger rate of 1 : 0.4187462 between the company and Korea-based biomedical company.1,436,618 new shares will be issued for the merger.Merger effective date of July 1.After the merger the company will survive and Korea-based biomedical company will be dissolved.Listing date of July 18 for the new shares. 

Company Quote

20.0 +0.96%
19 Dec 2014